The FDA warning listed several brand names of metoclopramide-containing products, that may lead to Tardive Dyskinesia and they include.
â€¢ Reglan Tablets
â€¢ Reglan Oral Disintegrating Tablets
â€¢ Reglan Injection
â€¢ Metoclopramide Oral Solution
There have been many products through out the years to try to help manage these problems but the one ingredient in the product that is used in these products that is causing the problems is metoclopramide.
The symptoms feature a personâ€™s ability to live a normal life and many of them are irreversible. Some of the symptoms they are not necessarily limited to:
â€¢ Involuntary/ repetitive movements of the extremities
â€¢ Impaired movement of the fingers
â€¢ Tongue convexity
â€¢ Lip smacking, pursing and puckering
â€¢ Rapid eye movements or blinking
The FDA has few remedies when a substance draws unwanted attention such as this one. Right now at this point two remedies have been administrated. The first is that they must require a â€˜black box warningâ€™ that is to be placed to all products containing metoclopramide that must be detail the risk as was described above. The second remedy is that a risk evaluation and moderation strategy or REMS be done. The REMs is designed to weigh the risks vs. the reward of using this product to provide additional warning to the users of these products.
Article Source: https://www.bharatbhasha.com
Article Url: https://www.bharatbhasha.com/legal.php/228540
Article Added on Thursday, April 1, 2010
|Legal >> Top 50 Articles on Legal|
|Category - >|